Toxic effects of gentamicin on marrow-derived human mesenchymal stem cells

Clinical Orthopaedics and Related Research

Volumn 452, Issue , 2006, Pages 242-249

  Chang, Yuhan ^a,b   Goldberg, Victor M ^c   Caplan, Arnold I ^a,c  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b CHANG GUNG UNIVERSITY   (Taiwan)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; COLLAGEN TYPE 10; COLLAGEN TYPE 2; DNA; GENTAMICIN; ANTIINFECTIVE AGENT;

ANIMAL EXPERIMENT; ARTICLE; BONE DEVELOPMENT; BONE MARROW CELL; CELL CULTURE; CELL ISOLATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DNA CONTENT; ENZYME ACTIVITY; EXPOSURE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; CYTOLOGY; DRUG EFFECT;

ANTI-BACTERIAL AGENTS; BONE MARROW CELLS; GENTAMICINS; HUMANS; MESENCHYMAL STEM CELLS;

EID: 33750633626     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1097/01.blo.0000229324.75911.c7     Document Type: Article

References (39)

1. Ashhurst DE. Collagens synthesized by healing fractures. Clin Orthop Relat Res. 1990;255:273-283.
2. Carrino DA, Arias JL, Caplan AI. A spectrophotometric modification of a sensitive densitometric Safranin O assay for glycosaminoglycans. Biochem Int. 1991;24:485-495.
3. Dennis JE, Haynesworth SE, Young RG, Caplan AI. Osteogenesis in marrow-derived mesenchymal cell porous ceramic composites transplanted subcutaneously: effect of fibronectin and laminin on cell retention and rate of osteogenic expression. Cell Transplant. 1992;1:23-32.
4. D'Ippolito G, Schiller PC, Ricordi C, Roos BA, Howard GA. Age-related osteogenic potential of mesenchymal stromal stem cells from human vertebral bone marrow. J Bone Miner Res. 1999;14:1115-1122.
5. Edin ML, Miclau T, Lester GE, Lindsey RW, Dahners LE. Effect of cefazolin and vancomycin on osteoblasts in vitro. Clin Orthop Relat Res. 1996;333:245-251.
6. Gerhart TN, Roux RD, Horowitz G, Miller RL, Hanff P, Hayes WC. Antibiotic release from an experimental biodegradable bone cement. J Orthop Res. 1988;6:585-592.
7. Haynesworth SE, Goshima J, Goldberg VM, Caplan AI. Characterization of cells with osteogenic potential from human marrow. Bone. 1992;13:81-88.
8. Hedstrom SA, Lidgren L, Torholm C, Onnerfalt R. Antibiotic containing bone cement beads in the treatment of deep muscle and skeletal infections. Acta Orthop Scand. 1980;51:863-869.
9. Isefuku S, Joyner CJ, Simpson AH. Toxic effect of rifampicin on human osteoblast-like cells. J Orthop Res. 2001;19:950-954.
10. Isefuku S, Joyner CJ, Simpson AH. Gentamicin may have an adverse effect on osteogenesis. J Orthop Trauma. 2003;17:212-216.
11. Jaiswal N, Haynesworth SE, Caplan AI, Bruder SP. Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. J Cell Biochem. 1997;64:295-312.
12. Justesen J, Stenderup K, Eriksen EF, Kassem M. Maintenance of osteoblastic and adipocytic differentiation potential with age and osteoporosis in human marrow stromal cell cultures. Calcif Tissue Int. 2002;71:36-44.
13. Kahlmeter G, Dahlager JI. Aminoglycoside toxicity: a review of clinical studies published between 1975 and 1982. J Antimicrob Chemother. 1984;13:9-22.
14. Klemm KW. Antibiotic bead chains. Clin Orthop Relat Res. 1993;295:63-76.
15. Lazzarini L, Mader JT, Calhoun JH. Osteomyelitis in long bones. J Bone Joint Surg Am. 2004;86:2305-2318.
16. Lennon DP, Edmison JM, Caplan AI. Cultivation of rat marrow-derived mesenchymal stem cells in reduced oxygen tension: effects on in vitro and in vivo osteochondrogenesis. J Cell Physiol. 2001;187:345-355.
17. Lennon DP, Haynesworth SE, Bruder SP, Jaiswal N, Caplan AI. Human and animal mesenchymal progenitor cells from bone marrow: identification of serum for optimal selection and proliferation. In Vitro Cell Dev Biol. 1996;32:602-611.
18. McKibbin B. The biology of fracture healing in long bones. J Bone Joint Surg Br. 1978;60:150-162.
19. Miclau T, Edin ML, Lester GE, Lindsey RW, Dahners LE. Bone toxicity of locally applied aminoglycosides. J Orthop Trauma. 1995;9:401-406.
20. Miclau T, Edin ML, Lester GE, Lindsey RW, Dahners LE. Effect of ciprofloxacin on the proliferation of osteoblast-like MG-63 human osteosarcoma cells in vitro. J Orthop Res. 1998;16:509-512.
21. Mueller SM, Glowacki J. Age-related decline in the osteogenic potential of human bone marrow cells cultured in three-dimensional collagen sponges. J Cell Biochem. 2001;82:583-590.
22. Murray WR. Use of antibiotic-containing bone cement. Clin Orthop Relat Res. 1984;190:89-95.
23. Ponticiello MS, Schinagl RM, Kadiyala S, Barry FP. Gelatin-based resorbable sponge as a carrier matrix for human mesenchymal stem cells in cartilage regeneration therapy. J Biomed Mater Res. 2000;52:246-255.
24. Reddi AH. Bone and cartilage differentiation. Curr Opin Genet Dev. 1994;4:737-744.
25. Reddi AH. Cell biology and biochemistry of endochondral bone development. Coll Relat Res. 1981;1:209-226.
26. Rockwood CA Jr, Green DP, Bucholz RW, Heckman JD. Rockwood and Green's Fractures in Adults. 4th ed. Philadelphia, PA: Lippincott-Raven; 1996.
27. Salvati EA, Callaghan JJ, Brause BD, Klein RF, Small RD. Reimplantation in infection: elution of gentamicin from cement and beads. Clin Orthop Relat Res. 1986;207:83-93.
28. Smilack JD, Flittie WH, Williams TW Jr. Bone concentrations of antimicrobial agents after parenteral administration. Antimicrob Agents Chemother. 1976;9:169-171.
29. Solchaga LA, Penick K, Porter JD, Goldberg VM, Caplan AI, Welter JF. FGF-2 enhances the mitotic and chondrogenic potentials of human adult bone marrow-derived mesenchymal stem cells. J Cell Physiol. 2005;203:398-409.
30. Stenderup K, Justesen J, Eriksen EF, Rattan SI, Kassem M. Number and proliferative capacity of osteogenic stem cells are maintained during aging and in patients with osteoporosis. J Bone Miner Res. 2001;16:1120-1129.
31. Topping RE, Bolander ME, Galian G. Type X collagen in fracture callus and the effects of experimental diabetes. Clin Orthop Relat Res. 1994;308:220-228.
32. Vecsei V, Barquet A. Treatment of chronic osteomyelitis by necrectomy and gentamicin-PMMA beads. Clin Orthop Relat Res. 1981;159:201-207.
33. Wahlig H, Dingeldein E. Antibiotics and bone cements: experimental and clinical long-term observations. Acta Orthop Scand. 1980;51:49-56.
34. Wahlig H, Dingeldein E, Bergmann R, Reuss K. The release of gentamicin from polymethylmethacrylate beads: an experimental and pharmacokinetic study. J Bone Joint Surg Br. 1978;60:270-275.
35. Williams RJ III, Attia E, Wickiewicz TL, Hannafin JA. The effect of ciprofloxacin on tendon, paratendon, and capsular fibroblast metabolism. Am J Sports Med. 2000;28:364-369.
36. Yao KL, Todescan R Jr, Sodek J. Temporal changes in matrix protein synthesis and mRNA expression during mineralized tissue formation by adult rat bone marrow cells in culture. J Bone Miner Res. 1994;9:231-240.
37. Yoo JU, Barthel TS, Nishimura K, Solchaga L, Caplan AI, Goldberg VM, Johnstone B. The chondrogenic potential of human bone-marrow-derived mesenchymal progenitor cells. J Bone Joint Surg Am. 1998;80:1745-1757.
38. Yoo JU, Johnstone B. The role of osteochondral progenitor cells in fracture repair. Clin Orthop Relat Res. 1998;355(suppl):S73-S81.
39. Zalavras CG, Patzakis MJ, Holtom P. Local antibiotic therapy in the treatment of open fractures and osteomyelitis. Clin Orthop Relat Res. 2004;427:86-93.